TuHURA Biosciences, Inc. Common Stock (HURA)

PHARMACEUTICAL PREPARATIONS

TuHURA Biosciences, Inc. Common Stock (HURA) is listed on Nasdaq, where it has traded since October 18, 2024.

Listed On
Nasdaq
Listed Since
October 18, 2024
Employees
22
Market Cap
$132M

About TuHURA Biosciences, Inc. Common Stock

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 87 institutions reported holding HURA, with 8.9 million shares worth $20.9 million in aggregate. The largest reported holder was Vanguard, with 2.5 million shares worth $5.9 million. Of the 5 largest holders listed below, 1 opened a new position in HURA, 2 added shares and 2 reduced their positions during the quarter.

InstitutionSharesValueQuarter change
Vanguard2,528,771$6MAdded 6.65%
Northern Trust1,621,042$4MAdded 443.63%
BlackRock690,088$2MReduced 71.84%
Geode Capital Management484,219$1MReduced 50.94%
Millennium Management454,535$1MNew position

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is HURA?

TuHURA Biosciences, Inc. Common Stock (HURA) is listed on Nasdaq, where it has traded since October 18, 2024.

Who are the largest institutional holders of HURA?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of HURA were Vanguard, Northern Trust and BlackRock.

How many institutions own HURA?

87 institutions reported a position in HURA for the quarter ended June 30, 2026, worth $20.9 million in total.

Did institutions buy or sell HURA last quarter?

Of the 5 largest reported holders, 1 opened a new position in HURA, 2 added shares and 2 reduced their positions during the quarter. Every reported holder and its change is on the SentiSense ownership page for HURA.

Every reported institutional holder, plus insider and congressional trades in HURA, on SentiSense.